Interim results from the ELiPSE-1 study: A phase 1, multicenter, open-label study of CNTY-101 in subjects with relapsed or refractory CD19-positive B-cell malignancies - Namburi, Swathi; Latif, Tahir; Oluwole, Olalekan O.; Cross, Scott J.; Simmons, Gary; Iragavarapu, Chaitanya; Hu, Bei; Jih, Gloria; Bullaughey, Kevin; Das, Poulomee A; Devlin, Elizabeth; Flowers, Kevin; et al. (Journal of clinical oncology, 2024)